ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0CUM Strategic Partners A/s

61,590.00
0.00 (0.00%)
22 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Strategic Partners A/s LSE:0CUM London Ordinary Share DK0062502894 STRATEGIC PARTNERS ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 61,590.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 0 -26.05M -0.7377 -122.00 2.17T

Notice to convene Annual General Meeting

25/04/2023 9:27pm

GlobeNewswire Inc.


Strategic Partners A/s (LSE:0CUM)
Historical Stock Chart


From Jan 2023 to Jan 2025

Click Here for more Strategic Partners A/s Charts.
Notice to convene Annual General Meeting

Company announcement                                                 

Orphazyme A/SNo. 03/2023Ole Maaløes Vej 3DK-2200 Copenhagen N                                                                                                                 www.orphazyme.comCompany Registration No. 32266355

Copenhagen, Denmark, April 25, 2023 – Orphazyme A/S (ORPHA.CO) (the “Company”), today announces the notice to convene the Company’s Annual General Meeting to be held on:

Wednesday, May 17, 2023 at 11:00 AM (CEST)

at the offices of Gorrissen Federspiel, Axeltorv 2, DK-1609 Copenhagen V.

The notice to convene the Annual General Meeting, including Appendix 1: Candidates for the Board of Directors is attached.

Additional information about the Annual General Meeting is available on the Company’s website: https://orphazyme.gcs-web.com/annual-general-meeting-0

For additional information, please contact

Orphazyme A/S

Anders Vadsholt, Chief Executive Officer and Chief Financial Officer: +45 28 98 90 55

Forward-looking statement This company announcement may contain certain forward-looking statements under the U.S. Private Securities Litigation Reform Act of 1995 and otherwise, including forward-looking statements about the Company’s annual meeting, annual and interim reports and timing thereof. Although the Company believes its expectations are based on reasonable assumptions, all statements other than statements of historical fact included in this company announcement about future events are subject to (i) change without notice and (ii) factors beyond the Company’s control, including pursuant to regulatory or judicial intervention. Except as required by law, the Company assumes no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future.

Attachments

  • Orphazyme - Company announcement - Notice to convene AGM 2023
  • Notice to Convene AGM 2023
  • Appendix 1 - Candidates for the Board of Directors

1 Year Strategic Partners A/s Chart

1 Year Strategic Partners A/s Chart

1 Month Strategic Partners A/s Chart

1 Month Strategic Partners A/s Chart

Your Recent History

Delayed Upgrade Clock